KIMS Hospitals Q1 FY27 Revenue Surges 36.1% YoY to ₹1,196 Cr; PAT Declines
KIMS Hospitals reported Q1 FY27 consolidated revenue of ₹1,196 crore, up 36.1% YoY. EBITDA rose 20.1% YoY to ₹240 crore. However, PAT declined 56.5% YoY to ₹37 crore, with EPS at ₹1.04. Cash and equivalents were ₹505 crore. The company added a new hospital in Palakkad.
The substantial revenue growth is a positive indicator for the company's expansion and operational capabilities. However, the decline in profitability metrics like PAT and EPS may temper investor enthusiasm, suggesting a medium impact.
The company reported strong revenue growth, which is positive. However, a significant decline in PAT and EPS, along with reduced EBITDA margins, indicates mixed financial performance, leading to a neutral sentiment.
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported a consolidated revenue of ₹1,196 crore, marking a significant year-on-year growth of 36.1% and a quarter-on-quarter growth of 10.3%. EBITDA stood at ₹240 crore, up 20.1% YoY and 10.9% QoQ, though the EBITDA margin decreased to 20.1% from 22.7% in Q1 FY26. Profit After Tax (PAT) for the quarter was ₹37 crore, a decline from ₹85 crore in Q1 FY26 and ₹33 crore in Q4 FY26. Consolidated Earnings Per Share (EPS) was ₹1.04, a decrease of 47.2% YoY.
Consolidated revenue from operations reached ₹1,179.5 crore, a 35.3% YoY increase. EBITDA (Pre-INDAS) was ₹222 crore, showing a 14.6% YoY growth. EBITDA (Pre-INDAS and excluding Other Income) was ₹206 crore, a 10.2% YoY increase. The company's cash and cash equivalents stood at ₹505 crore as of June 30, 2026.
Operationally, Average Revenue Per Occupied Bed (ARPOB) grew by 9.7% YoY and 0.1% QoQ, while Average Revenue Per Patient (ARPP) grew by 6.8% YoY but declined by 3.8% QoQ. The company also highlighted several clinical achievements across its various hospital units, including complex surgeries and new medical milestones. Dr. B Bhaskara Rao, CMD, KIMS Hospitals, noted a robust start to Q1 FY27 with the addition of a new hospital in Palakkad, Kerala, and expressed satisfaction with the performance of new units and overall footfalls, expecting continued healthy topline and bottom line for the rest of FY27.
KIMS Hospitals operates 26 hospitals with over 8,300 beds across five states, with plans to expand its bed capacity to 9,600+.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.